Mark Lazarus
Impact in
- Rheumatology top 5%
- Systemic Lupus Erythematosus Research
- Rheumatoid Arthritis Research and Therapies
- Transplantation top 5%
- Renal Transplantation Outcomes and Treatments
Papers in
-
- Systemic Lupus Erythematosus Research 4
- Rheumatoid Arthritis Research and Therapies 1
- Oncology 3
- Cytokine Signaling Pathways and Interactions 2
- Cancer Immunotherapy and Biomarkers 1
- Cutaneous Melanoma Detection and Management 1
- Co-authors
- David M. Turner (2 shared papers)P. J. Sinnott (2 shared papers)Ian V. Hutchinson (2 shared papers)David Sankaran (1 shared paper)William Ollier (1 shared paper)Ali H. Hajeer (1 shared paper)Jane Worthington (1 shared paper)David Alan Isenberg (2 shared papers)
- Journals
- Lara D. Veeken (2 papers)Medical Oncology (1 paper)European Journal of Immunology (1 paper)Annals of the Rheumatic Diseases (1 paper)European Journal of Immunogenetics (1 paper)
- Partner nations
- United KingdomUnited StatesSweden
In The Last Decade
Mark Lazarus
8 papers receiving 1.9k citations
Mark Lazarus's Hit Papers
Peers
Comparison fields: 5 of 73
- Rheumatology 303
- Transplantation 51
- Biological Psychiatry 16
- Periodontics 73
- Genetics 320
Countries citing papers authored by Mark Lazarus
This map shows the geographic impact of Mark Lazarus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Lazarus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Lazarus more than expected).
Fields of papers citing papers by Mark Lazarus
This network shows the impact of papers produced by Mark Lazarus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Lazarus. The network helps show where Mark Lazarus may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Lazarus, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | AN INVESTIGATION OF POLYMORPHISM IN THE INTERLEUKIN‐10 GENE PROMOTER Hit paper breakdown → | 1997 | 1527 |
| 2 | Genetic variation in the interleukin 10 gene promoter and systemic lupus erythematosus. | 1997 | 217 |
| 3 | 2012 | 67 | |
| 4 | 2009 | 49 | |
| 5 | 2024 | 49 | |
| 6 | 2012 | 5 | |
| 7 | 2011 | 2 | |
| 8 | 2016 | 2 |
About Mark Lazarus
Mark Lazarus is a scholar working on Rheumatology, Oncology, Pharmacology, Immunology and Genetics, having authored 8 papers that have together received 1.9k indexed citations. Recurring topics across this work include Systemic Lupus Erythematosus Research (4 papers), Cytokine Signaling Pathways and Interactions (2 papers), Cancer Immunotherapy and Biomarkers (1 paper), Clinical practice guidelines implementation (1 paper), Rheumatoid Arthritis Research and Therapies (1 paper), Immunotherapy and Immune Responses (1 paper), Cutaneous Melanoma Detection and Management (1 paper) and Genetic Associations and Epidemiology (1 paper). The work is most often cited by research in Rheumatology (303 citations), Transplantation (51 citations), Biological Psychiatry (16 citations), Periodontics (73 citations) and Genetics (320 citations). Mark Lazarus has collaborated with scholars based in United Kingdom, United States and Sweden. Frequent co-authors include David M. Turner, P. J. Sinnott, Ian V. Hutchinson, David Sankaran, William Ollier, Ali H. Hajeer, Jane Worthington, David Alan Isenberg, Michael R. Ehrenstein and Tabitha Turner‐Stokes. Their work appears in journals such as Lara D. Veeken, Medical Oncology, European Journal of Immunology, Annals of the Rheumatic Diseases and European Journal of Immunogenetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.